ArticleIndian journal of anaesthesia2025
Supraglottic airway devices versus endotracheal tube in children undergoing adenotonsillectomy - A systematic review and meta-analysis.
Article in Indian journal of anaesthesia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: The use of supraglottic airway devices (SGADs) is still controversial in paediatric otorhinolaryngological surgeries. We conducted this review and analysis to compare SGADs to endotracheal tubes (ETTs) regarding the feasibility of their use in children. Methods: Randomised controlled trials (RCTs) that compared SGADs versus ETTs in patients ≤18 years undergoing adenotonsillectomy surgery under general anaesthesia were searched from PubMed, Cochrane Central Register of Controlled Trials (CENTRAL), Scopus, and Embase till November 2024 and re-examined on 31 August 2025. The primary outcome measure was conversion from SGAD to ETT, and other outcomes included comparison of perioperative respiratory adverse events, laryngospasm, and surgical time. Results: Six trials ( Conclusion: SGADs are a feasible alternative to ETT in paediatric adenotonsillectomy with an anticipated failure rate of 6.5%. Larger and more rigorous RCTs are needed to establish the safety of these airway devices in terms of PRAE and efficacy in terms of duration of surgery in comparison to ETTs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.